Diabetes Technology Discussion Forum highlights
The advent of Continuous Glucose Monitors (CGMs) has significantly improved the lives of those living with diabetes; however, the high cost remains a barrier for many.
Recently, the YDA collaborated with experts from the UK, Singapore, and Australia to discuss how their governments support the use of this remarkable technology, and more importantly, how YDA can advocate for similar support in Hong Kong.
The Diabetes Technology Discussion Forum, titled “Empowering Progress: Achieving Equitable Access to Diabetes Technology in Hong Kong,” brought together YDA members, healthcare professionals, professors, and CGM manufacturers.
We were honored to hear from international speakers, including Professor Partha Kar from the UK, Dr. Daphne Gardner from Singapore, and Professor Alicia Jenkins from Australia. Additionally, Professor Elaine Chow and Dr. Julianna Lui from The Chinese University of Hong Kong (CUHK) shared valuable insights.
We also had the privilege of welcoming our special guest speaker, Dr. Hon David Lam, a member of the Legislative Council.
The World Health Organization projects a significant increase in the number of individuals living with diabetes globally, with an estimated rise to 643 million by 2030, up from 537 million in 2021.
Living with diabetes can be life-threatening if not managed properly. Individuals with Type 1 diabetes (T1D), in particular, require daily insulin doses. Effective management involves maintaining good control of blood glucose levels (HbA1c), which can be especially challenging for young people.
A few key insights shared at the Forum:
1. Data shows that CGMs reduce HbA1c by 0.5-1%, significantly decreasing diabetes complications and hypoglycaemic episodes, yet only 10% of children and young people with T1D in Hong Kong currently utilise CGM compared to nearly 25% in developed nations.
2. YDA data revealed that, of 526 respondents, 92% have used CGM, with 80% being continuous users. However, 94.7% would stop if costs remain high.
3. Australia used a phased approach to CGM subsidies, emphasising the importance of a united effort among all stakeholders including diabetes associations, healthcare providers and patients.
A comprehensive report from the Forum will be shared in due course.
Together we will make a difference. A heartfelt thank you to all the speakers and participants for making the event a success.
